Genome-wide association study for Atopy and Allergic Rhinitis in a Singapore Chinese population

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Andiappan, Anand Kumar ^a   Wang, De Yun ^a   Anantharaman, Ramani ^a   Parate, Pallavi Nilkanth ^a   Suri, Bani Kaur ^a   Low, Hui Qi ^b   Li, Yi ^b   Zhao, Wanting ^b   Castagnoli, Paola ^c   Liu, Jianjun ^b   Chew, Fook Tim ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

^c AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; B CELL ADAPTOR FOR PHOSPHATIDYLINOSITOL 3 KINASE; HLA DQ ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MITOCHONDRIAL RIBOSOMAL PROTEIN L4; NEUROPEPTIDE RECEPTOR; NEUROPEPTIDE S RECEPTOR 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RIBOSOME PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ATOPY; B CELL ADAPTOR FOR PHOSPHATIDYLINOSITOL 3 KINASE GENE; CHINESE; CHROMOSOME 10Q; CHROMOSOME 19Q; CHROMOSOME 6; CONTROLLED STUDY; DNA FLANKING REGION; ETHNIC GROUP; FEMALE; GENE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HLA DQ GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL RIBOSOMAL PROTEIN L4 GENE; NPSR1 GENE; SIGNAL TRANSDUCTION; SINGAPORE; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN; CASE CONTROL STUDY; COMPARATIVE STUDY; GENETICS; HYPERSENSITIVITY; PHENOTYPE; RHINITIS;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; HYPERSENSITIVITY; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RHINITIS; SINGAPORE; YOUNG ADULT;

EID: 79956344245     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019719     Document Type: Article

References (62)

1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, et al. (2008) Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63: 8-+.
2. Nathan RA, (2007) The burden of allergic rhinitis. Allergy and Asthma Proceedings 28: 3-9.
3. Reed SD, Lee TA, McCrory DC, (2004) The economic burden of allergic rhinitis- A critical evaluation of the literature. Pharmacoeconomics 22: 345-361.
4. Bousquet J, van Cauwenberge P, Khaltaev N, Ait-Khaled N, Annesi-Maesano I, et al. (2001) Allergic rhinitis and its impact on asthma. Journal of Allergy and Clinical Immunology 108: S147-S334.
5. Falade AG, Ige OM, Yusuf BO, Onadeko MO, Onadeko BO, (2009) Trends in the Prevalence and Severity of Symptoms of Asthma, Allergic Rhinoconjunctivitis, and Atopic Eczema. Journal of the National Medical Association 101: 414-418.
6. Mosges R, Klimek L, (2007) Today's allergic rhinitis patients are different: new factors that may play a role. Allergy 62: 969-975.
7. Blumenthal MN, Langefeld CD, Beaty TH, Bleecker ER, Ober C, et al. (2004) A genome-wide search for allergic response (atopy) genes in three ethnic groups: Collaborative Study on the Genetics of Asthma. Human Genetics 114: 157-164.
8. Hakonarson H, Halapi E, Bjornsdottir US, Upmanyu R, Soebech E, et al. (2002) Genome-wide search in asthma and atopy patients identifies multiple loci of genome-wide significance. American Journal of Human Genetics 71: 139.
9. Maksimovic N, Tomic-Spiric V, Jankovic S, Jovic-Vranes A, Terzic-Supic Z, et al. (2010) Risk factors of allergic rhinitis: a case-control study. Healthmed 4: 63-70.
10. Sih T, Mion O, (2010) Allergic rhinitis in the child and associated comorbidities. Pediatric Allergy and Immunology 21: E107-E113.
11. Bousquet J, Annesi-Maesano I, Carat F, Leger D, Rugina M, et al. (2005) Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clinical and Experimental Allergy 35: 728-732.
12. Choi SH, Yoo Y, Yu J, Rhee CS, Min YG, et al. (2007) Bronchial hyperresponsiveness in young children with allergic rhinitis and its risk factors. Allergy 62: 1051-1056.
13. Blumenthal MN, Yunis E, Mendell N, Elston RC, (1986) PREVENTIVE ALLERGY- GENETICS OF IGE-MEDIATED DISEASES. Journal of Allergy and Clinical Immunology 78: 962-968.
14. Blumenthal MN, (2005) The role of genetics in the development of asthma and atopy. Current Opinion in Allergy and Clinical Immunology 5: 141-145.
15. Hurme M, Pessi T, Karjalainen J, (2003) Genetics of inflammation and atopy. Annals of Medicine 35: 256-258.
16. Postma DS, Koppelman GH, Meyers DA, (2000) The genetics of atopy and airway hyperresponsiveness. American Journal of Respiratory and Critical Care Medicine 162: S118-S123.
17. MacLean JA, Eidelman FJ, (2001) The genetics of atopy and atopic eczema. Archives of Dermatology 137: 1474-1476.
18. Bazaral M, Orgel HA, Hamburge Rn, (1974) GENETICS OF IGE AND ALLERGY- SERUM IGE LEVELS IN TWINS. Journal of Allergy and Clinical Immunology 54: 288-304.
19. Clarke JR, Jenkins MA, Hopper JL, Carlin JB, Mayne C, et al. (2000) Evidence for genetic associations between asthma, atopy, and bronchial hyperresponsiveness- A study of 8-to 18-yr-old twins. American Journal of Respiratory and Critical Care Medicine 162: 2188-2193.
20. Duffy DL, Mitchell CA, Martin NG, (1998) Genetic and environmental risk factors for asthma- A cotwin-control study. American Journal of Respiratory and Critical Care Medicine 157: 840-845.
21. Kim JS, Ouyang FX, Pongracic JA, Fang YP, Wang BY, et al. (2008) Dissociation between the prevalence of atopy and allergic disease in rural China among children and adults. Journal of Allergy and Clinical Immunology 122: 929-935.
22. Bouzigon E, Asthma Metaanalysis G, (2007) Meta-analysis of genome-wide linkage studies for asthma and atopy phenotypes, using an extended GSMA method. Genetic Epidemiology 31: 45.
23. Denham S, Koppelman GH, Blakey J, Wjst M, Ferreira MA, et al. (2008) Meta-analysis of genome-wide linkage studies of asthma and related traits. Respiratory Research 9.
24. Jun JE, Wilson LE, Vinuesa CG, Lesage S, Blery M, et al. (2003) Identifying the MAGUK protein CARMA-1 as a central regulator of humoral immune responses and atopy by genome-wide mouse mutagenesis. Immunity 18: 751-762.
25. Koppelman GH, Stine OC, Xu JF, Howard TD, Zheng SQL, et al. (2002) Genome-wide search for atopy susceptibility genes in Dutch families with asthma. Journal of Allergy and Clinical Immunology 109: 498-506.
26. Ober C, Tsalenko A, Willadsen S, Newman D, Daniel R, et al. (1999) Genome-wide screen for atopy susceptibility alleles in the Hutterites. Clinical and Experimental Allergy 29: 11-15.
27. Vercelli D, (2008) Discovering susceptibility genes for asthma and allergy. Nature Reviews Immunology 8: 169-182.
28. Moffatt MF, Kabesch M, Liang LM, Dixon AL, Strachan D, et al. (2007) Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature 448: 470-U475.
29. Zhang GC, Goldblatt J, LeSouef P, (2009) The era of genome-wide association studies: opportunities and challenges for asthma genetics. Journal of Human Genetics 54: 624-628.
30. Willis-Owen SAG, Cookson WO, Moffatt MF, (2009) Genome-Wide Association Studies in the Genetics of Asthma. Current Allergy and Asthma Reports 9: 3-9.
31. Li XN, Howard TD, Zheng SL, Haselkorn T, Peters SP, et al. (2010) Genome-wide association study of asthma identifies RAD50-IL13 and HLA-DR/DQ regions. Journal of Allergy and Clinical Immunology 125: 328-335.
32. Andiappan AK, Anantharaman R, Nilkanth PP, Wang DY, Chew FT, (2010) Evaluating the transferability of Hapmap SNPs to a Singapore Chinese population. Bmc Genetics 11.
33. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003) TRANSFAC (R): transcriptional regulation, from patterns to profiles. Nucleic Acids Research 31: 374-378.
34. Kel AE, Gossling E, Reuter I, Cheremushkin E, Kel-Margoulis OV, et al. (2003) MATCH (TM): a tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Research 31: 3576-3579.
35. Pare G, Chasman DI, Kellogg M, Zee RYL, Rifai N, et al. (2008) Novel Association of ABO Histo-Blood Group Antigen with Soluble ICAM-1: Results of a Genome-Wide Association Study of 6,578 Women. Plos Genetics 4.
36. Campbell A, Chanal I, Czarlewski W, Michel FB, Bousquet J, (1997) Reduction of soluble ICAM-1 levels in nasal secretion by H-1-blockers in seasonal allergic rhinitis. Allergy 52: 1022-1025.
37. Juuti-Uusitalo KM, Kaukinen K, Maki M, Tuimala J, Kainulainen H, (2006) Gene expression in TGFbeta-induced epithelial cell differentiation in a three-dimensional intestinal epithelial cell differentiation model. Bmc Genomics 7.
38. Williams TM, Moolten D, Burlein J, Romano J, Bhaerman R, et al. (1991) IDENTIFICATION OF A ZINC FINGER PROTEIN THAT INHIBITS IL-2 GENE-EXPRESSION. Science 254: 1791-1794.
39. Ikeda K, Halle JP, Stelzer G, Meisterernst M, Kawakami K, (1998) Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6. Molecular and Cellular Biology 18: 10-18.
40. Okada T, Maeda A, Iwamatsu A, Gotoh K, Kurosaki T, (2000) BCAP: The tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity 13: 817-827.
41. Yamazaki T, Takeda K, Gotoh K, Takeshima H, Akira S, et al. (2002) Essential immunoregulatory role for BCAP in B cell development and function. Journal of Experimental Medicine 195: 535-545.
42. Yamazaki T, Kurosaki T, (2003) Contribution of BCAP to maintenance of mature B cells through c-Rel. Nature Immunology 4: 780-786.
43. MacFarlane AW, Yamazaki T, Fang M, Sigal LJ, Kurosaki T, et al. (2008) Enhanced NK-cell development and function in BCAP-deficient mice. Blood 112: 131-140.
44. Aiba Y, Kameyama M, Yamazaki T, Tedder TF, Kurosaki T, (2008) Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase. Blood 111: 1497-1503.
45. Held W, (2008) Inhibitions in NK-cell maturation. Blood 112: 8-9.
46. Hardy RR, Hayakawa K, (2001) B cell development pathways. Annual Review of Immunology 19: 595-621.
47. Wen RR, Wang DM, (2001) Phospholipase C gamma 2 is essential in the functions of B cell receptor. Faseb Journal 15: A320-A320.
48. Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, et al. (2002) T-H cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nature Immunology 3: 643-651.
49. Cousins DJ, McDonald J, Lee TH, (2008) Therapeutic approaches for control of transcription factors in allergic disease. Journal of Allergy and Clinical Immunology 121: 803-809.
50. Chang HC, Han L, Jabeen R, Carotta S, Nutt SL, et al. (2009) PU.1 Regulates TCR Expression by Modulating GATA-3 Activity. Journal of Immunology 183: 4887-4894.
51. Lennartsson A, Garwicz D, Lindmark A, Gullberg U, (2005) The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding. Gene 356: 193-202.
52. Kim SR, Lee KS, Park HS, Park SJ, Min KH, et al. (2010) HIF-1α inhibition ameliorates an allergic airway disease via VEGF suppression in bronchial epithelium. European Journal of Immunology 40: 2858-2869.
53. Park SJ, Lee YC, (2009) PTEN/PI3K PATHWAY AS A THERAPEUTIC TARGET FOR ALLERGIC AIRWAYS INFLAMMATION. Drugs of the Future 34: 673-680.
54. Lee KS, Kim SR, Park SJ, Min KH, Lee KY, et al. (2008) Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1 alpha-VEGF axis. American Journal of Respiratory and Critical Care Medicine 178: 787-797.
55. Moon H, Park S, Kim S, Lee K, Choe Y, et al. (2008) Mast cells can mediate vascular permeability through regulation of PI3K-HIF-1 alpha-VEGF axis. Allergy 63: 274.
56. Benita Y, Kikuchi H, Smith AD, Zhang MQ, Chung DC, et al. (2009) An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Research 37: 4587-4602.
57. Voelkel NF, Spiegel S, (2009) Why is effective treatment of asthma so difficult? An integrated systems biology hypothesis of asthma. Immunology and Cell Biology 87: 601-605.
58. Vogtel M, Michels A, (2010) Role of intermittent hypoxia in the treatment of bronchial asthma and chronic obstructive pulmonary disease. Current Opinion in Allergy and Clinical Immunology 10: 206-213.
59. Olson N, Hristova M, Lounsbury K, van der Vliet A, (2010) Contribution Of Hypoxia Inducible Factor (HIF-1) To Airway Epithelial Barrier Protection During Oxidant Injury. American Journal of Respiratory and Critical Care Medicine 181: A1446-.
60. Kabesch M, (2010) Next generation genetics in allergy. Current Opinion in Allergy and Clinical Immunology 10: 407-407.
61. Anantharaman R, Chew FT, (2009) Validation of pooled genotyping on the Affymetrix 500 k and SNP6.0 genotyping platforms using the polynomial-based probe-specific correction. Bmc Genetics 10.
62. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, et al. (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nature Genetics 38: 904-909.